神经调节设备市场规模、份额、成长分析、按产品、按应用、按最终用途、按地区 - 按行业预测，2024-2031 年

2022年神经调节剂的全球市场规模估值为51.3亿美元，从2023年的55.8亿美元增长到2031年的108.7亿美元，预计在预测期内（2024-2031年）将以复合年增长率增长。

由于慢性病的盛行率不断增加以及这些疾病的药物治疗的局限性，神经调节剂市场正在迅速扩大。对人类神经功能特性和电刺激效果的广泛研究推动了神经调节技术的进步。用于控制疼痛的脊髓刺激和用于治疗癫痫的迷走神经刺激等创新疗法正变得越来越普遍，凸显了标靶治疗的演变。对神经退化性疾病的认识不断提高以及神经调节应用开发的进步是关键的成长动力。然而，高营运成本和缺乏技术纯熟劳工等挑战可能会阻碍预测期内的市场扩张，需要采取策略性方法来解决这些障碍。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 专利分析
• 案例研究

神经调节剂市场规模：依产品分类

• 市场概况
• 脊髓刺激设备
• 深层脑部刺激器
• 荐骨神经刺激器
• 迷走神经刺激设备
• 胃电刺激
• 其他的

神经调节剂市场规模：依应用分类

• 市场概况
• 帕金森氏症
• 慢性疼痛
• 癫痫
• 偏头痛
• 尿失禁和大便失禁
• 发抖
• 忧郁症
• 其他的

神经调节剂市场规模：依最终用途分类

• 市场概况
• 医院和门诊手术中心 (ASC)
• 诊所和物理治疗中心
• 其他的

按地区分類的神经调节剂市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Medtronic
• Synapse Biomedical
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• Nevro Corp.
• NeuroSigma Inc.
• NeuroPace Inc.
• Cyberonics Inc.
• NDI Medical LLC
• NeuroMetrix Inc.
• NeuroVista Corporation
• Neuronetics Inc.
• BioControl Medical
• SPR Therapeutics
• MicroTransponder Inc.
• Soterix Medical Inc.
• BrainsWay Ltd.
• Saluda Medical Pty Ltd

结论和建议

Global Neuromodulation Devices Market size was valued at USD 5.13 billion in 2022 and is poised to grow from USD 5.58 billion in 2023 to USD 10.87 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The neurostimulation market is expanding rapidly due to the increasing prevalence of chronic conditions and the limitations of pharmaceutical treatments for these diseases. Advances in neurostimulation techniques have been driven by extensive research into the functional properties of human nerves and the effects of electrical stimulation. Innovative treatments, such as spinal cord stimulation for pain management and vagus nerve stimulation for epilepsy, are gaining traction, highlighting the evolution of targeted therapies. The surge in awareness of neurodegenerative diseases and ongoing developments in neuromodulation applications are key growth drivers. However, challenges such as high operational costs and a shortage of skilled workforce may impede market expansion during the forecast period, necessitating strategic approaches to address these hurdles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neuromodulation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neuromodulation Devices Market Segmental Analysis

Global Neuromodulation Devices Market is segmented by Product, Application, End-use, and region. Based on Product, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Gastric Electrical Stimulation, Others. Based on Application, the market is segmented into Parkinson's Disease, Chronic Pain, Epilepsy, Migraine, Urinary & Faecal Incontinence, Tremor, Depression, Others. Based on End-use, the market is segmented into Hospitals & Ambulatory Surgery Centers (ASC), Clinics & Physiotherapy Centers, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Neuromodulation Devices Market

The global neuromodulation devices market is influenced by several driving factors. A significant contributor to the market's growth is the rising prevalence of health concerns among diverse populations. Neuromodulation devices have gained popularity as effective solutions for managing chronic pain, including conditions such as shoulder pain, headaches, and brain injuries, showcasing their remarkable ability to provide relief across a spectrum of ailments. Furthermore, these devices are increasingly utilized for treating mental health issues, digestive disorders, and sleep-related problems. Consequently, the expanding adoption of neuromodulation technology for addressing a wide range of health conditions is significantly propelling the market forward.

Restraints in the Global Neuromodulation Devices Market

The global neuromodulation devices market faces significant obstacles stemming from several factors. Primarily, the substantial capital investment required poses a considerable barrier to entry, making it difficult for emerging players to establish themselves in the industry. Additionally, the high production costs associated with manufacturing neuromodulation devices further exacerbate this challenge, restricting market growth. Furthermore, the market is impeded by a shortage of skilled professionals, as effective utilization of these devices necessitates expertise and specialized training. This lack of qualified personnel hampers the broader adoption and implementation of neuromodulation therapies, ultimately constraining market expansion.

Market Trends of the Global Neuromodulation Devices Market

The Global Neuromodulation Devices market is experiencing significant growth, driven by an increasing number of patients with chronic conditions such as back pain, depression, epilepsy, and sleep apnea exhibiting resistance to traditional drug therapies. This shift towards neurostimulation methods reflects a proactive response from healthcare practitioners who are seeking more effective solutions for slow-progressing treatments and inadequate outcomes. As the demand for alternative management strategies grows, neuromodulation devices are being increasingly recognized for their potential to enhance patient quality of life, thus propel market expansion, ensuring a promising future for innovative therapeutic approaches in chronic disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Neuromodulation Devices Market Size by Product & CAGR (2024-2031)

• Market Overview
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Gastric Electrical Stimulation
• Others

Global Neuromodulation Devices Market Size by Application & CAGR (2024-2031)

• Market Overview
• Parkinson's Disease
• Chronic Pain
• Epilepsy
• Migraine
• Urinary & Faecal Incontinence
• Tremor
• Depression
• Others

Global Neuromodulation Devices Market Size by End-use & CAGR (2024-2031)

• Market Overview
• Hospitals & Ambulatory Surgery Centers (ASC)
• Clinics & Physiotherapy Centers
• Others

Global Neuromodulation Devices Market Size & CAGR (2024-2031)

• North America (Product, Application, End-use)
  • US
  • Canada
• Europe (Product, Application, End-use)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NDI Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroMetrix Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroVista Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioControl Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SPR Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTransponder Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrainsWay Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saluda Medical Pty Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation